\-\ Texto\\:\\ \ \(0\)\
\-\ optic\\ atrophy\ \(2\)\
\-\ low\\ serum\\ testosterone\\ levels\\.\ \(0\)\
\-\ t3\\ and\\ t4\\ levels\\ low\\ normal\ \(0\)\
\-\ lesion\\ was\\ resected\\ and\\ is\\ pathologically\\ proven\\.\\ \ \(0\)\
\-\ hormone\\ replacement\\ therapy\ \(4\)\
\-\ 1\\.2\\ cm\\ enhancing\\ mass\\ involving\\ the\\ pituitary\\ stalk\ \(1\)\
\-\ mild\\ compression\\ of\\ chiasm\\.\ \(0\)\
\-\ hemangioblastoma\\,\\ pituitary\\ stalk\ \(0\)\
\-\ \\â\\€\\¢\\ rathke\\ cleft\\ cyst\ \(0\)\
\-\ \\â\\€\\¢\\ hypothalamic\\ glioma\ \(0\)\
\-\ \\â\\€\\¢\\ craniopharyngioma\ \(0\)\
\-\ \\â\\€\\¢\\ eosinophilic\\ granuloma\\ \\(langerhan\\ histiocytosis\ \(0\)\
\-\ \\â\\€\\¢\\ pituitary\\ adenoma\ \(1\)\
\-\ \\â\\€\\¢\\ hamartoma\\ of\\ the\\ tuber\\ cinereum\ \(0\)\
\-\ 33\\ year\\ old\\ man\\ presented\\ with\\ visual\\ field\\ problems\ \(1\)\
\-\ post\\ operative\\ scans\\ reveal\\ complete\\ tumor\\ removal\\.\\ \\ no\\ evidence\\ of\\ residual\\ infundibulum\\.\\ \\ tumor\\ completely\\ replaced\\ the\\ pituitary\\ stalk\\ at\\ surgery\\.\\ \\ this\\ is\\,\\ obviously\\,\\ a\\ very\\ unusual\\ location\\ and\\ presentation\\ for\\ hemangioblastoma\\.\\ \\ \\ most\\ commonly\\,\\ hemangioblastoma\\ is\\ a\\ cerebellar\\ lesion\\;\\ and\\,\\ is\\ associated\\ with\\ von\\ hippel\\-lindau\\ disease\\ in\\ about\\ 20\\%\\ of\\ cases\\.\\ \\ more\\ on\\ hemangioblastoma\\:\ \(0\)\
\-\ \\â\\€\\¢\\ images\\ \\-\\ http\\:\\/\\/rad\\.usuhs\\.edu\\/medpix\\/medpix\\.html\\?mode\\=image\\_finder\\&srchstr\\=hemangioblastoma\\&srch\\_type\\=all\\&action\\=search\\#top\ \(0\)\
\-\ \\â\\€\\¢\\ topics\\ \\-\\ http\\:\\/\\/rad\\.usuhs\\.edu\\/medpix\\/medpix\\.html\\?mode\\=tsearch2\\&srchstr\\=hemangioblastoma\\#top\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.4462422110112291\ \(0\)\
\-\ pituitary\\:\\ 0\\.27439298730947365\ \(0\)\
\-\ stalk\\:\\ 0\\.2580081890522245\ \(0\)\
\-\ top\\:\\ 0\\.14515904861714707\ \(0\)\
\-\ levels\\:\\ 0\\.11791656780819681\ \(0\)\
\-\ http\\:\\ 0\\.1099609098464315\ \(0\)\
\-\ cinereum\\:\\ 0\\.10698506090007588\ \(0\)\
\-\ tuber\\:\\ 0\\.10460812466481471\ \(0\)\
\-\ topics\\:\\ 0\\.10460812466481471\ \(0\)\
\-\ obviously\\:\\ 0\\.09932205359047898\ \(0\)\
\-\ testosterone\\:\\ 0\\.09670589861798666\ \(0\)\
\-\ infundibulum\\:\\ 0\\.09266239163727691\ \(0\)\
\-\ langerhan\\:\\ 0\\.09028545540201574\ \(0\)\
\-\ pathologically\\:\\ 0\\.08653492828788822\ \(0\)\
\-\ low\\:\\ 0\\.08534564551957327\ \(0\)\
\-\ hypothalamic\\:\\ 0\\.08499938432768002\ \(0\)\
\-\ replaced\\:\\ 0\\.08406776985591825\ \(0\)\
\-\ von\\:\\ 0\\.0823832293551877\ \(0\)\
\-\ is\\:\\ 0\\.08146484602020654\ \(0\)\
\-\ rathke\\:\\ 0\\.08124885721355252\ \(0\)\
\-\ t3\\:\\ 0\\.08054397985490622\ \(0\)\
\-\ chiasm\\:\\ 0\\.07893241786361402\ \(0\)\
\-\ tumor\\:\\ 0\\.07779767007875327\ \(0\)\
\-\ hormone\\:\\ 0\\.07572356740198563\ \(0\)\
\-\ proven\\:\\ 0\\.07503117166745502\ \(0\)\
\-\ t4\\:\\ 0\\.07458919526035043\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.07458919526035043\ \(0\)\
\-\ hamartoma\\:\\ 0\\.07315058152652977\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.07239459843645389\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.07185505708088738\ \(0\)\
\-\ lesion\\:\\ 0\\.07130745023277779\ \(0\)\
\-\ atrophy\\:\\ 0\\.07035872233938557\ \(0\)\
\-\ field\\:\\ 0\\.06989581967515078\ \(0\)\
\-\ resected\\:\\ 0\\.06806056009238873\ \(0\)\
\-\ residual\\:\\ 0\\.0676713653581611\ \(0\)\
\-\ granuloma\\:\\ 0\\.06729345323423781\ \(0\)\
\-\ cleft\\:\\ 0\\.06716987832424634\ \(0\)\
\-\ replacement\\:\\ 0\\.06680602990761245\ \(0\)\
\-\ serum\\:\\ 0\\.06668696921352239\ \(0\)\
\-\ unusual\\:\\ 0\\.06668696921352239\ \(0\)\
\-\ completely\\:\\ 0\\.06645206095918486\ \(0\)\
\-\ 33\\:\\ 0\\.06544440511989642\ \(0\)\
\-\ scans\\:\\ 0\\.06471120479683426\ \(0\)\
\-\ problems\\:\\ 0\\.06450907585814143\ \(0\)\
\-\ optic\\:\\ 0\\.06401705311167899\ \(0\)\
\-\ visual\\:\\ 0\\.06345013529854972\ \(0\)\
\-\ glioma\\:\\ 0\\.06317566083662604\ \(0\)\
\-\ reveal\\:\\ 0\\.06255683696132819\ \(0\)\
\-\ operative\\:\\ 0\\.06238529428382536\ \(0\)\
\-\ and\\:\\ 0\\.06146903574423671\ \(0\)\
\-\ cerebellar\\:\\ 0\\.060859221486687536\ \(0\)\
\-\ adenoma\\:\\ 0\\.05929003349389022\ \(0\)\
\-\ of\\:\\ 0\\.058214037900310905\ \(0\)\
\-\ removal\\:\\ 0\\.05684606854854454\ \(0\)\
\-\ about\\:\\ 0\\.055674606608371015\ \(0\)\
\-\ commonly\\:\\ 0\\.05502882995234852\ \(0\)\
\-\ compression\\:\\ 0\\.054459849966580806\ \(0\)\
\-\ very\\:\\ 0\\.05334869609536212\ \(0\)\
\-\ complete\\:\\ 0\\.0521293916963859\ \(0\)\
\-\ involving\\:\\ 0\\.05209064856120717\ \(0\)\
\-\ location\\:\\ 0\\.05178477985977089\ \(0\)\
\-\ presentation\\:\\ 0\\.05119376397066201\ \(0\)\
\-\ cases\\:\\ 0\\.05002032721062923\ \(0\)\
\-\ 20\\:\\ 0\\.04797769276368537\ \(0\)\
\-\ enhancing\\:\\ 0\\.04658718162885145\ \(0\)\
\-\ the\\:\\ 0\\.044517396469173555\ \(0\)\
\-\ presented\\:\\ 0\\.04336726796984634\ \(0\)\
\-\ cyst\\:\\ 0\\.04290021902579014\ \(0\)\
\-\ therapy\\:\\ 0\\.04272930106642479\ \(0\)\
\-\ cm\\:\\ 0\\.042710447765390756\ \(0\)\
\-\ evidence\\:\\ 0\\.0422114492279796\ \(0\)\
\-\ mild\\:\\ 0\\.042157165782198774\ \(0\)\
\-\ more\\:\\ 0\\.04083604525469506\ \(0\)\
\-\ post\\:\\ 0\\.04046606080227968\ \(0\)\
\-\ surgery\\:\\ 0\\.03998344006137608\ \(0\)\
\-\ man\\:\\ 0\\.03937139949059551\ \(0\)\
\-\ associated\\:\\ 0\\.039197569510065984\ \(0\)\
\-\ most\\:\\ 0\\.03870341513256658\ \(0\)\
\-\ images\\:\\ 0\\.034400200908293946\ \(0\)\
\-\ disease\\:\\ 0\\.03121708959447631\ \(0\)\
\-\ normal\\:\\ 0\\.03036399964668432\ \(0\)\
\-\ with\\:\\ 0\\.029124410387042353\ \(0\)\
\-\ mass\\:\\ 0\\.02840663180362582\ \(0\)\
\-\ at\\:\\ 0\\.02808977569031344\ \(0\)\
\-\ was\\:\\ 0\\.025918021753644004\ \(0\)\
\-\ this\\:\\ 0\\.025554221007887543\ \(0\)\
\-\ no\\:\\ 0\\.02418366235496649\ \(0\)\
\-\ year\\:\\ 0\\.022918786558394615\ \(0\)\
\-\ for\\:\\ 0\\.022540402641492128\ \(0\)\
\-\ on\\:\\ 0\\.02246044498274501\ \(0\)\
\-\ old\\:\\ 0\\.022009968630909184\ \(0\)\
\-\ in\\:\\ 0\\.018500371602846077\ \(0\)\
